Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: A possible mechanism of action via regulation of retinoid receptors expression

International Journal of Cancer

Volumn 78, Issue 2, 1998, Pages 248-254

  Liu, Guizhong ^a,b   Wu, Min ^a   Levi, Giovanni ^b   Ferrari, Nicoletta ^b  

^a CANCER HOSPITAL   (China)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DRUG RECEPTOR BINDING; ESOPHAGUS CARCINOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FENRETINIDE; HUMANS; LUNG NEOPLASMS; NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031665586     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981005)78:2<248::AID-IJC20>3.0.CO;2-5     Document Type: Article

References (34)

1. BISSONETTE, R.P., ECHEVERRY, F., MAHBOUBI, A. and GREEN, D.R., Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (Lond), 359, 552-554 (1992).
2. CAI, Y.H., GU, Y.W., ZHANG, J.Q., LU, P. and ZHOU, Q.H., Establishment of a human stomach adenocarcinoma cell line BGC-823. J. Beijing Med. Univ., 18, 136-139 (1986).
3. CHAMBON, P., The retinoid signaling pathway: molecular and genetic analyses. Semin. cell Biol., 5, 115-125 (1994).
4. COLLINS, S.J., ROBERTSON, K.A. and MUELLER L., Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol. cell. Biol., 10, 2154-2163 (1990).
5. CÔTÉ, S. and MOMPARLER, R., Activation of the retinoic acid receptor β gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells. Anti-Cancer Drugs, 8, 56-61 (1997).
6. DETHÉ, H., VIVANCO-RUIZ, M.M., TIOLLAIS, P., STUNNENBERG, H.A. and DEJEAN, A., Identification of a retinoic acid response element in the retinoic acid receptor β gene. Nature (Lond), 343, 177-180 (1990).
7. FANJUL, A., DELIA, D., PIEROTTI, M.A., RIDEOUT, D., QIU, J. and PFAHL, M., 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. biol. Chem., 271, 22441-22446 (1996).
8. FERRARI, N., VIDALI, G. and PFEFFER, U., Use of quantitative PCR to study retinoid receptor expression. Methods Enzymol., 282, 48-64 (1997).
9. GEBERT, J.F., MOGHAL, N., FRANGIONI, J.V., SUGARBAKER, D.J. and NEEL, B.G., High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6, 1859-1868 (1991).
10. GIANNINI, F., MAESTRO, R., VUKOSAVLJEVIC, T., POMPONI, F. and BOIOCCHI, M., All-trans. 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use. Int. J. Cancer, 70, 194-200 (1997).
11. GREGER, V., DEBUS, N., LOHMANN, D., HOPPING, W., PASSARGE, E. and HORSTHEMKE, B., Frequency and parental origin of hypermethylated Rb1 alleles in retinoblastoma. Hum. Genet., 94, 491-496 (1994).
12. GUDAS, L.J., SPORN, M.B. and ROBERTS, A.B., Cellular biology and biochemistry of the retinoids. In M.B. Sporn, A.B. Roberts and D.S. Goodman (eds.), The retinoids, 2nd ed., pp. 443-520, Raven Press, New York (1994).
13. HAZEL, T.G., NATHANS, D. and LAU, L.F., A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. nat. Acad. Sci. (Wash.), 85, 8444-8448 (1988).
14. HERMAN, J.G., LATIF, F., WENG, Y., LERMAN, M.I., ZBAR, B., LIU, S., SAMID, D., DUAN, D.S., GNARRA, J.R. and LINEMAN, W.M., Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 9700-9704 (1994).
15. HERMAN, J.G., JEN, J., MERLO, A. and BAYLIN, S.B., Hypermethylation-associated interaction indicates a tumor suppressor role for p15INK4B. Cancer Res., 56, 722-727 (1996).
16. JONES, P.A. and TAYLOR, S.M., Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20, 1324-1333 (1979).
17. KAMEI, Y., XU, L., HEINZEL, T., TORCHIA, J., KUROKAWA, R., GLOSS, B., LIN, S.C., HEYMAN, R.A., ROSE, B., GLASS, C.K. and ROSENFELD, M.G., A CBP integrater complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85, 403-414 (1996).
18. KASTNER, P., KRUST, A., MENDELSOHN, C., GARNIER. J.-M., ZELENT, P. LEROY, A., STAUB, A. and CHAMBON, P., Murine isoforms of retinoic acid receptor γ with specific patterns of expression. Proc. nat. Acad. Sci. (Wash.), 87, 2700-2704 (1990).
19. LEROY, P., KRUST, A., ZELENT, A., MENDELSOHN, C. GARNIER, J.-M., KASTNER, P., DIERICH, A. and CHAMBON, P., Multiple isoforms of the mouse retinoic acid receptor a are generated by alternative splicing and differential induction by retinoic acid. EMBO J., 10, 59-69 (1991).
20. LIANG, M.D., JIA, W., HU, M.Y, WANG, Z.X., LIU, G.Y. and ZHOU, K.M., Establishment of a human lung adenocarcinoma cell line GLC-82. Acta Acad. Med. Kunming. 5, 1-6 (1984).
21. LIN, M., Establishment of a human esophageal squamous cell carcinoma cell line. Chinese Med., 56, 412-415 (1976).
22. LIPPMAN, S.M., KESSLER, J.F. and MEYSKENS, F.L., Retinoids as preventive and therapeutic anticancer agents. Cancer Treat. Rep., 71, 493-515 (1987).
23. LIU, Y., LEE, M.O., WANG, H.G., LI, Y., HASHIMOTO, Y., KLAUS, M., REED, J.C. and ZHANG, X.K., RARβ mediates the growth inhibitory effect of retinoic acid by inducing cell apoptosis in human breast cancer cells. Mol. cell Biol., 16, 1138-1149 (1996).
24. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5'-CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature (Med.), 1, 686-692 (1995).
25. MOSMANN, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. immunol. Methods, 65, 55-63 (1983).
26. SEEWALDT, V.L., JOHNSON, B.S., PARKER, M.B., COLLINS, S.J. and SWISSHELM, K., Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differentiation, 6, 1077-1088 (1995).
27. SWISSHELM, K., RYAN, K., LEE, X., TSOU, H.C., BEACOCKE, M. and SAGER, R., Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differentiation 5, 133-141 (1994).
28. 3 receptors. Cell, 65, 1255-1266 (1991).
29. WILLIAMS, G.T. and LAU, L.F., Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol. cell. Biol., 13, 6124-6136 (1993).
30. WU, Q., DAWSON, M.I., ZHENG, Y., HOBBS, P., AGADIR, A., JONG, L., LI, Y., LIU, R., LIN, B. and ZHANG, X.K., Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol. cell. Biol., 17, 6598-6608 (1997a).
31. WU, Q., LI, Y., LIU, R., AGADIR, A., LEE, M.O., LIU, Y. and ZHANG, X.K., Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J., 16, 1656-1669 (1997b).
32. ZELENT, A., MENDELSOHN, C., KASTNER, P., KRUST, A., GARNIER, J.-M., RUFFENACH, F., LEROY, P. and CHAMBON, P., Differentially expressed isoforms of the mouse retinoic acid receptor β are generated by usage of two promoter and alternative splicing. EMBO J., 10, 71-81 (1991).
33. ZHANG, X.-K., LIU, Y., LEE, M.-O. and PFAHL, M., A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54, 5663-5669 (1994).
34. ZHANG, X.-K., LIU, Y. and LEE, M.-O., Retinoid receptors in human lung cancer and breast cancer. Mutation Res., 350, 267-277 (1996).